RxDoctor Payments Data

Rodney Muhammad, DO

Adult Medicine · Colorado Springs, CONPI 1659481430

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 13 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 9 manufacturers reported payments, led by Medtronic at 32.5% of the total.

$465in general payments, 2019–2025

Across 13 payments — averaging $35.74 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$151
  • Amgen$84
  • AstraZeneca$78
  • Inspire Medical Systems, Inc.$61
  • Baxter Healthcare$25
  • Lundbeck LLC$19
  • plus $46 from 3 others

What the payments were for

  • Food & beverage$465100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Medtronic1$151
Amgen(2 entities)3$84
AstraZeneca3$78
Inspire Medical Systems, Inc.1$61
Baxter Healthcare1$25
Lundbeck LLC1$19
AbbVie1$16
Bayer1$15
Pfizer1$15

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

Too few adult medicine providers in Coloradoto place this figure against a meaningful peer group, so we don't.

Medicare billing

Part B allowed, 2024
$41,179
Medicare patients
174
Services billed
632

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Fluticasone-SalmeterolFluticasone Propion/Salmeterol12$2,197
Diclofenac Sodium-MisoprostolDiclofenac Sodium/Misoprostol11$933
SynthroidLevothyroxine Sodium11$673
Gabapentin33$444
Atorvastatin Calcium44$286
Losartan Potassium28$279
Lisinopril33$253
Montelukast Sodium13$225
Levothyroxine Sodium24$222
Allopurinol12$159
Ibandronate Sodium12$130
Fluoxetine Hcl21$125
Pantoprazole Sodium11$123
Amlodipine Besylate27$104
Losartan-HydrochlorothiazideLosartan/Hydrochlorothiazide15$103

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AbbVieSynthroid$16$67311 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. There are too few adult medicine providers in Coloradoon file to place this against a meaningful peer group, so we don't.

Other adult medicine in Colorado Springs

See the full list for Colorado

Where these figures come from

Is this you, or does something look wrong? →